$91.50+58.25% · 3M
Moving avg
1W+7.96%
1M+25.81%
3M+48.47%
6M+30.68%
YTD+37.51%
1Y+14.43%
3Y-20.96%
5Y-27.69%
52-week range
$54.11100% of range$89.98
Company health
Value0/6
Growth6/6
Profitability5/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (3383%)
- Revenue compounding 30% a year
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$34.53B
Enterprise value
$28.58B
P/E ratio (TTM)
30.57x
P/S ratio (TTM)
5.88x
EV/EBITDA
19.36x
Per share & returns
EPS (TTM)
$2.42
Dividend yield
0.00%
Beta (1Y)
1.45
30-day change
+25.81%
Trading
Volume (24h)
1.61M
Previous close
$90.80
Shares outstanding
377.36M
About DexCom, Inc.
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Symbol
DXCM
DexCom, Inc. is a large-cap healthcare company in the Medical - Devices industry. Its shares are listed on NASDAQ (United States) and trade under the ticker DXCM.
Frequently asked questions
What is DexCom, Inc.'s market cap?
DexCom, Inc. (DXCM) has a market capitalization of $34.53B.
What is DexCom, Inc.'s P/E ratio?
DexCom, Inc. trades at a price-to-earnings (P/E) ratio of 30.57.
What exchange does DXCM trade on?
DXCM trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.02-0.02%
$1.15T cap
Johnson & JohnsonJNJ
$261.21+0.13%
$629.49B cap
AbbVie Inc.ABBV
$250.31+0.62%
$442.25B cap
UnitedHealth Group IncorporatedUNH
$403.33-0.56%
$366.28B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.58+1.25%
$332.39B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap